Conflict of interest: Can we minimize its influence in the biomedical literature?

Journal of the American Board of Family Practice

Volumn 18, Issue 5, 2005, Pages 411-413

  Neale, Anne Victoria ^a,c   Schwartz, Kendra L ^a   Bowman, Marjorie A ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; CLINICAL PRACTICE; DRUG INDUSTRY; EDITORIAL; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH PRACTITIONER; MARKETING; MEDICAL CARE; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL PROFESSION; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION;

EID: 27944469182     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.18.5.411     Document Type: Editorial

References (19)

1. Genius SJ. The proliferation of clinical practice guidelines: professional development or medicine-by-numbers? J Am Board Fam Pract 2005;18:419-25.
2. Abramson J, Starfield B. The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine? J Am Board Fam Pract 2005;18: 414-8.
3. Thompson D. Understanding financial conflicts of interest. N Engl J Med 1993;329:573-6.
4. [Editorial]. Publishing commentary by authors with potential conflicts of interest: When, why, and how. Ann Intern Med 2004;141:73-4.
5. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003;29: 252-5.
6. Bowman MA. The impact of drug company funding on the content of continuing medical education. Möbius 1986;6:66-9.
7. Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Cont Educ Health Prof 1988;8:13-20.
8. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 2000;283:373-80.
9. Chervenak FA, McCullough LB. An ethical framework for identifying, preventing, and managing conflicts confronting leaders of academic health centers. Acad Med 2004;79:1056-61.
10. Perlis CS, Harwood M, Perlis RH. Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol 2005;52: 967-71.
11. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: Epidemiological study of randomized clinical trials published in the. BMJ 2002;325:249.
12. Schulman KA, Seils DM, Timbie JW, Sugarman J, Dame LA, Weinfurt KP, Mark DB, Califf RM. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002;347:1335-41.
13. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287: 612-7.
14. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med 2004;19:51-6.
15. Charlton BG. Conflicts of interest in medical science: peer usage, peer review and 'Col consultancy'. Med Hypotheses 2004;63:181-6.
16. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002;346:1901-2.
17. International Committee of Medical Journal Editors. "Uniform Requirements for Manuscripts Submitted to Biomedical Journals." Available at: www.icmje.org. Accessed July 5, 2005.
18. DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001;286:89-91.
19. Davidoff F, DeAngelis C, Drazen JM, Hoey J, Hojharrd L, Horton R. Sponsorship, authorship, and accountability. Lancet 2001;358:854-6.